Why This Matters for Patients
Understanding how a telehealth platform makes money helps you evaluate whether its incentives are aligned with your interests. A platform that makes more money when you buy more compounds has different incentives than one that charges a flat monthly fee regardless of which compounds you use.
The Two Primary Revenue Models
Per-transaction model: Platforms charge for each consultation, each compound, and each refill separately. Revenue grows when patients use more compounds. This creates incentive pressure toward prescribing more compounds or higher doses than may be clinically necessary.
All-inclusive subscription model: Platforms charge a flat monthly fee covering physician consultation, compound, and shipping. Revenue is stable regardless of which specific compounds a patient uses. This better aligns platform incentives with patient outcomes — you want patients to get results and stay subscribed, not to maximize per-transaction revenue.
Pharmacy Margin
Telehealth platforms typically purchase compounded medications from pharmacy partners at wholesale rates ($80-120 for compounds that retail at $180-250) and keep the margin. This is standard in healthcare — pharmacies, PBMs, and distributors all operate on margins. Transparency about which pharmacy is used allows patients to verify that wholesale pricing relationships exist with legitimate, quality-verified partners.
My Body Labs’ Model
My Body Labs uses all-inclusive monthly pricing. One number covers membership, physician oversight, compound, and shipping. We make more money when patients stay subscribed — which means we make more money when patients get results from their protocols. This is the alignment structure we believe is most appropriate for a healthcare platform.